Latest News

FDA Removes Partial Hold for Myotonic Dystrophy Agent AOC 1001
FDA Removes Partial Hold for Myotonic Dystrophy Agent AOC 1001

October 10th 2024

FDA Action Update, September 2024: Approvals, Designations, and Clearances
FDA Action Update, September 2024: Approvals, Designations, and Clearances

October 10th 2024

Duchenne Gene Therapy Shows No Alteration of Cardiac Outcomes in Phase 3 EMBARK Study
Duchenne Gene Therapy Shows No Alteration of Cardiac Outcomes in Phase 3 EMBARK Study

October 10th 2024

Capricor Submits BLA for Approval of Dermiocel in Treating DMD Cardiomyopathy
Capricor Submits BLA for Approval of Dermiocel in Treating DMD Cardiomyopathy

October 9th 2024

Coverage of the 40th Congress of the European Committee for Treatment and Research in MS

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor in Copenhagen.

ECTRIMS 2024

Conference Coverage

View All
Duchenne Gene Therapy Shows No Alteration of Cardiac Outcomes in Phase 3 EMBARK Study
Duchenne Gene Therapy Shows No Alteration of Cardiac Outcomes in Phase 3 EMBARK Study

October 10th 2024

Mechanism of Stem Cell Therapy Bemdaneprocel for Parkinson Disease: Amit Rakhit, MD
Mechanism of Stem Cell Therapy Bemdaneprocel for Parkinson Disease: Amit Rakhit, MD

October 9th 2024

Exploring the Impact of Circadian Rhythms on Glial Function and Alzheimer Disease
Exploring the Impact of Circadian Rhythms on Glial Function and Alzheimer Disease

October 9th 2024

NeuroVoices: Joseph Kuchling, MD, on Bridging Gaps in Autoimmune Condition Overlap With New MS Diagnostic Criteria
NeuroVoices: Joseph Kuchling, MD, on Bridging Gaps in Autoimmune Condition Overlap With New MS Diagnostic Criteria

October 9th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.